Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Dr. Joel Salinas, clinical assistant professor of neurology at NYU Langone Health and chief medical officer at Isaac Health, spoke with Cheddar News anchor Shannon LaNier about Alzheimer's disease and struggles to find an effective treatment.
A meta-analysis published in Current Biology suggests men who get fewer than six hours of sleep a night leading up to a vaccination had a weaker antibody response compared to those who got more sleep.
At its annual health event on Tuesday, Google announced a series of changes to its search tool that it said will make it easier to access information about affordable health care services.
